Vertex Joins Protein Degradation Space with Kymera Therapeutics Collaboration

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 5 (Table of Contents)

Published: 23 May-2019

DOI: 10.3833/pdr.v2019.i5.2428     ISSN: 1756-7874

Section: Research & Development



Signalling that it also sees promise in the targeted protein degradation space, Vertex has entered a four-year collaboration with Kymera Therapeutics to develop up to six small molecule protein degraders...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details